JP2019524834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524834A5 JP2019524834A5 JP2019508879A JP2019508879A JP2019524834A5 JP 2019524834 A5 JP2019524834 A5 JP 2019524834A5 JP 2019508879 A JP2019508879 A JP 2019508879A JP 2019508879 A JP2019508879 A JP 2019508879A JP 2019524834 A5 JP2019524834 A5 JP 2019524834A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- epilepsy
- agent according
- patient
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376488P | 2016-08-18 | 2016-08-18 | |
| US62/376,488 | 2016-08-18 | ||
| PCT/US2017/047505 WO2018035408A1 (en) | 2016-08-18 | 2017-08-18 | Methods of treating developmental disorders with biguanides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019524834A JP2019524834A (ja) | 2019-09-05 |
| JP2019524834A5 true JP2019524834A5 (cg-RX-API-DMAC7.html) | 2020-09-24 |
Family
ID=61190982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508879A Pending JP2019524834A (ja) | 2016-08-18 | 2017-08-18 | ビグアナイド系による発達障害の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10123979B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3484452A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019524834A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190039974A (cg-RX-API-DMAC7.html) |
| CN (1) | CN109715144A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017313823A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3033967A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019001937A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018035408A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10295547B2 (en) | 2013-03-14 | 2019-05-21 | University Of Florida Research Foundation, Incorporated | Use and treatment of di-amino acid repeat-containing proteins associated with ALS |
| US10509045B2 (en) | 2015-05-29 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Methods for diagnosing Huntington's disease |
| US10940161B2 (en) | 2016-04-04 | 2021-03-09 | University Of Florida Research Foundation, Incorporated | Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation |
| WO2018035408A1 (en) | 2016-08-18 | 2018-02-22 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with biguanides |
| EP3612190A4 (en) * | 2017-04-17 | 2021-01-20 | University of Florida Research Foundation, Incorporated | REGULATION OF RAN TRANSLATION THROUGH PKR AND EIF2A-P WAYS |
| EP3688020A4 (en) | 2017-09-25 | 2021-07-14 | University of Florida Research Foundation, Incorporated | IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS |
| AU2018342105B2 (en) * | 2017-09-26 | 2023-11-16 | University Of Florida Research Foundation, Incorporated | Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders |
| GB201912760D0 (en) * | 2019-09-05 | 2019-10-23 | Healx Ltd | Treatment |
| AU2020348916B2 (en) | 2019-09-20 | 2025-12-18 | University Of Florida Research Foundation, Incorporated | Detection of antibodies against RAN proteins from serum and tissue lysates |
| WO2021072187A2 (en) | 2019-10-10 | 2021-04-15 | University Of Florida Research Foundation, Incorporated | Ran proteins as biomarkers in cag/ctg expansion disorders |
| GB202008699D0 (en) * | 2020-06-09 | 2020-07-22 | Healx Ltd | Treatment |
| CN113318111B (zh) * | 2021-06-21 | 2026-02-03 | 浙江大学 | Nav1.1激动剂在制备治疗自闭症的药物中的应用 |
| US20250041247A1 (en) * | 2021-12-01 | 2025-02-06 | University Of Florida Research Foundation, Incorporated | Small molecule inhibitors of repeat associated non-aug (ran) translation and combination therapies |
| US20230186023A1 (en) * | 2021-12-13 | 2023-06-15 | International Business Machines Corporation | Automatically assign term to text documents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| AU2003261298A1 (en) * | 2002-08-02 | 2004-02-23 | Penwest Pharmaceuticals Company | Sustained release formulations of metformin |
| US20060147947A1 (en) * | 2002-12-04 | 2006-07-06 | Javier Apfeld | AMPK pathway components |
| US8252321B2 (en) * | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| WO2008097861A2 (en) * | 2007-02-02 | 2008-08-14 | Braincells, Inc. | MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS |
| CN102058888B (zh) * | 2009-05-01 | 2014-06-11 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种治疗能量代谢异常的药物组合物和其应用 |
| EP2653158B1 (en) * | 2010-12-13 | 2017-07-05 | Fukuoka University | Therapeutic agent for blood-brain barrier disruption syndrome |
| EP3013371A4 (en) * | 2013-06-26 | 2017-04-26 | Rett Syndrome Research Trust | Rett syndrome and treatments therefore |
| WO2018035408A1 (en) | 2016-08-18 | 2018-02-22 | Ovid Therapeutics Inc. | Methods of treating developmental disorders with biguanides |
-
2017
- 2017-08-18 WO PCT/US2017/047505 patent/WO2018035408A1/en not_active Ceased
- 2017-08-18 CN CN201780057960.3A patent/CN109715144A/zh active Pending
- 2017-08-18 US US15/680,417 patent/US10123979B2/en active Active
- 2017-08-18 EP EP17842173.1A patent/EP3484452A4/en not_active Withdrawn
- 2017-08-18 AU AU2017313823A patent/AU2017313823A1/en not_active Abandoned
- 2017-08-18 MX MX2019001937A patent/MX2019001937A/es unknown
- 2017-08-18 CA CA3033967A patent/CA3033967A1/en not_active Abandoned
- 2017-08-18 KR KR1020197006647A patent/KR20190039974A/ko not_active Ceased
- 2017-08-18 JP JP2019508879A patent/JP2019524834A/ja active Pending
-
2018
- 2018-10-11 US US16/157,653 patent/US10426746B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10912754B2 (en) | Methods and compositions for treating excessive sleepiness | |
| AU2018201060B2 (en) | 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto | |
| US9718766B2 (en) | High penetration drugs and their compositions thereof for treatment of parkinson diseases | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| ES2988617T3 (es) | Norketotifeno para el tratamiento de la hipercitocinemia y las infecciones virales | |
| US20200179336A1 (en) | Methods of treating neurological and psychiatric disorders | |
| JP2004519469A5 (cg-RX-API-DMAC7.html) | ||
| JP2010518122A5 (cg-RX-API-DMAC7.html) | ||
| RU2011134499A (ru) | Композиция 4-амино-2-(2,6-диоксопиперидин-3-ил)изоиндолин-1,3-диона | |
| JP2011510014A5 (cg-RX-API-DMAC7.html) | ||
| JP2023550149A5 (cg-RX-API-DMAC7.html) | ||
| JP2011225596A5 (cg-RX-API-DMAC7.html) | ||
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| BRPI0605026A (pt) | composição farmacêutica estável de glimepirida com liberação imediata e metformina com liberação prolongada | |
| JP2021152060A (ja) | アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法 | |
| JP2022545156A5 (cg-RX-API-DMAC7.html) | ||
| JP2014508758A5 (cg-RX-API-DMAC7.html) | ||
| RU2013137645A (ru) | Аналоги цистамина, применяемые для лечения болезни паркинсона | |
| JP2021527053A5 (cg-RX-API-DMAC7.html) | ||
| JP2018531273A5 (cg-RX-API-DMAC7.html) | ||
| ES2905771T3 (es) | Composiciones y procedimientos para el tratamiento de la inflamación y del dolor | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| ES2315569T3 (es) | Procedimiento de tratamiento de trastornos del movimiento usando derivados de acido barbiturico. | |
| TW201828932A (zh) | 1,1-二甲基雙胍之亞硝酸鹽、醫藥組合物及使用方法 | |
| US11850220B2 (en) | Synthesis of ibuprofen hybrid conjugates as anti-inflammatory and analgesic agents |